Protagonist Therapeutics, Inc Increase (Decrease) in Prepaid Expense and Other Assets
Protagonist Therapeutics, Inc (PTGX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$2.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- Protagonist Therapeutics, Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$4.22M, a 484.41% decline year-over-year.
- Protagonist Therapeutics, Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.92M, a 102.32% increase year-over-year.
- Protagonist Therapeutics, Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $365.00K.
- Protagonist Therapeutics, Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$50.00K, a 104.30% decline year-over-year.
- Protagonist Therapeutics, Inc increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.36M, a 37.37% decline from fiscal 2024.
- Protagonist Therapeutics, Inc increase (decrease) in prepaid expense and other assets for fiscal 2024 was $3.77M.
- Protagonist Therapeutics, Inc increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.75M.
- Protagonist Therapeutics, Inc increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$3.75M, a 216.33% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.30M 10-Q · filed 2026-08-05 | -$1.93M derived: sum of 3 quarters · filed 2026-08-05 | -$1.98M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $1.92M 10-Q · filed 2026-05-05 | $2.28M derived: sum of 2 quarters · filed 2026-05-05 | $2.23M derived: sum of 3 quarters · filed 2026-05-05 | $3.33M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $315.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.41M derived: sum of 3 quarters · filed 2026-08-05 | $2.36M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.05M derived: sum of 2 quarters · filed 2026-08-05 | $2.00M 10-Q · filed 2025-11-06 | $1.68M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.04M 10-Q · filed 2026-08-05 | $1.73M derived: sum of 3 quarters · filed 2026-08-05 | $2.89M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $948.00K 10-Q · filed 2026-05-05 | $628.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.79M derived: sum of 3 quarters · filed 2026-05-05 | $3.80M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | -$320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $843.00K derived: sum of 2 quarters · filed 2026-02-25 | $2.85M derived: sum of 3 quarters · filed 2026-02-25 | $3.77M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.17M derived: sum of 2 quarters · filed 2025-11-06 | $4.09M 10-Q · filed 2025-11-06 | $3.92M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.92M 10-Q · filed 2025-08-06 | $2.75M derived: sum of 3 quarters · filed 2026-02-25 | $3.38M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $915.00K 10-Q · filed 2025-05-06 | $744.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.37M derived: sum of 3 quarters · filed 2026-02-25 | -$51.00K derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | -$171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $458.00K derived: sum of 2 quarters · filed 2026-02-25 | -$966.00K derived: sum of 3 quarters · filed 2026-02-25 | -$1.75M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $629.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$795.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.58M 10-Q · filed 2024-11-07 | -$4.92M derived: sum of 4 quarters · filed 2025-02-21 | ||
| 2023-06-30 | -$1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$2.21M 10-Q · filed 2024-08-06 | -$5.55M derived: sum of 3 quarters · filed 2025-02-21 | -$6.22M derived: sum of 4 quarters · filed 2025-02-21 | ||
| 2023-03-31 | -$787.00K 10-Q · filed 2024-05-07 | -$4.13M derived: sum of 2 quarters · filed 2025-02-21 | -$4.80M derived: sum of 3 quarters · filed 2025-02-21 | -$3.26M derived: sum of 4 quarters · filed 2025-02-21 | ||
| 2022-12-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$4.01M derived: sum of 2 quarters · filed 2025-02-21 | -$2.48M derived: sum of 3 quarters · filed 2025-02-21 | -$3.75M 10-K · filed 2025-02-21 | ||
| 2022-09-30 | -$668.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $866.00K derived: sum of 2 quarters · filed 2023-11-02 | -$413.00K 10-Q · filed 2023-11-02 | $182.00K derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $255.00K 10-Q · filed 2023-08-03 | $850.00K derived: sum of 3 quarters · filed 2024-02-27 | $2.06M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | -$1.28M 10-Q · filed 2023-05-04 | -$684.00K derived: sum of 2 quarters · filed 2024-02-27 | $527.00K derived: sum of 3 quarters · filed 2024-02-27 | $2.00M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.81M derived: sum of 2 quarters · filed 2024-02-27 | $3.28M derived: sum of 3 quarters · filed 2024-02-27 | $3.23M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.69M derived: sum of 2 quarters · filed 2022-11-08 | $2.63M 10-Q · filed 2022-11-08 | $2.17M derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2021-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.42M 10-Q · filed 2022-08-04 | $957.00K derived: sum of 3 quarters · filed 2023-03-15 | $2.27M derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2021-03-31 | -$57.00K 10-Q · filed 2022-05-05 | -$521.00K derived: sum of 2 quarters · filed 2023-03-15 | $797.00K derived: sum of 3 quarters · filed 2023-03-15 | $1.85M derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2020-12-31 | -$464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $854.00K derived: sum of 2 quarters · filed 2023-03-15 | $1.91M derived: sum of 3 quarters · filed 2023-03-15 | $1.10M 10-K · filed 2023-03-15 | ||
| 2020-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.37M derived: sum of 2 quarters · filed 2021-11-03 | $1.57M 10-Q · filed 2021-11-03 | $2.80M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $248.00K 10-Q · filed 2021-08-04 | $1.48M derived: sum of 3 quarters · filed 2022-02-28 | $1.26M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | -$806.00K 10-Q · filed 2021-05-04 | $428.00K derived: sum of 2 quarters · filed 2022-02-28 | $210.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.61M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.02M derived: sum of 2 quarters · filed 2022-02-28 | $2.41M derived: sum of 3 quarters · filed 2022-02-28 | $2.82M 10-K · filed 2022-02-28 | ||
| 2019-09-30 | -$218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $1.18M derived: sum of 2 quarters · filed 2020-11-04 | $1.59M 10-Q · filed 2020-11-04 | $995.00K derived: sum of 4 quarters · filed 2021-03-10 | ||
| 2019-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.80M 10-Q · filed 2020-08-06 | $1.21M derived: sum of 3 quarters · filed 2021-03-10 | $1.49M derived: sum of 4 quarters · filed 2021-03-10 | ||
| 2019-03-31 | $406.00K 10-Q · filed 2020-05-07 | -$185.00K derived: sum of 2 quarters · filed 2021-03-10 | $96.00K derived: sum of 3 quarters · filed 2021-03-10 | $439.00K derived: sum of 4 quarters · filed 2021-03-10 | ||
| 2018-12-31 | -$591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$310.00K derived: sum of 2 quarters · filed 2021-03-10 | $33.00K derived: sum of 3 quarters · filed 2021-03-10 | -$1.12M 10-K · filed 2021-03-10 | ||
| 2018-09-30 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $624.00K derived: sum of 2 quarters · filed 2019-11-06 | -$526.00K 10-Q · filed 2019-11-06 | $841.00K derived: sum of 4 quarters · filed 2020-03-10 | ||
| 2018-06-30 | $343.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$807.00K 10-Q · filed 2019-08-07 | $560.00K derived: sum of 3 quarters · filed 2020-03-10 | $1.22M derived: sum of 4 quarters · filed 2020-03-10 | ||
| 2018-03-31 | -$1.15M 10-Q · filed 2019-05-08 | $217.00K derived: sum of 2 quarters · filed 2020-03-10 | $881.00K derived: sum of 3 quarters · filed 2020-03-10 | $769.00K derived: sum of 4 quarters · filed 2020-03-10 | ||
| 2017-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $2.03M derived: sum of 2 quarters · filed 2020-03-10 | $1.92M derived: sum of 3 quarters · filed 2020-03-10 | $333.00K 10-K · filed 2020-03-10 | ||
| 2017-09-30 | $664.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $552.00K derived: sum of 2 quarters · filed 2018-11-06 | -$1.03M 10-Q · filed 2018-11-06 | $587.00K derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-06-30 | -$112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$1.70M 10-Q · filed 2018-08-07 | -$77.00K derived: sum of 3 quarters · filed 2019-03-12 | $1.24M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-03-31 | -$1.59M 10-Q · filed 2018-05-09 | $35.00K derived: sum of 2 quarters · filed 2019-03-12 | $1.35M derived: sum of 3 quarters · filed 2019-03-12 | $1.16M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2016-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $2.94M derived: sum of 2 quarters · filed 2019-03-12 | $2.75M derived: sum of 3 quarters · filed 2019-03-12 | $1.80M 10-K · filed 2019-03-12 | $1.80M 10-K · filed 2017-03-07 | |
| 2016-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.13M derived: sum of 2 quarters · filed 2017-11-07 | $183.00K 10-Q · filed 2017-11-07 | $179.00K 10-Q · filed 2016-11-14 | $1.30M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-06-30 | -$191.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$1.13M 10-Q · filed 2017-08-08 | -$16.00K derived: sum of 3 quarters · filed 2018-03-07 | $328.00K derived: sum of 4 quarters · filed 2018-03-07 | ||
| 2016-03-31 | -$943.00K 10-Q · filed 2017-05-10 | $175.00K derived: sum of 2 quarters · filed 2018-03-07 | $519.00K derived: sum of 3 quarters · filed 2018-03-07 | |||
| 2015-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $1.46M derived: sum of 2 quarters · filed 2018-03-07 | $1.53M 10-K · filed 2018-03-07 | $1.50M 10-K · filed 2017-03-07 | ||
| 2015-09-30 | $344.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $414.00K 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $70.00K 10-Q · filed 2016-09-15 | |||||
| 2014-12-31 | -$604.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |